Evidence map›Paper›PMID 35898123›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2022

Family directly observed therapy for children with drug-resistant TB.

M L Rekart, T Morshed, W K Mulanda, J Klieascikova, N Sitali, A Rajabzoda, S Avzamova, B Pirmahmadzoda, A Aung, M Sayfulloev and 2 more

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

M L RekartMedecins Sans Frontieres (MSF), Dushanbe, Tajikistan, MSF, Uzbekistan.
T MorshedMedecins Sans Frontieres (MSF), Dushanbe, Tajikistan.
W K MulandaMedecins Sans Frontieres (MSF), Dushanbe, Tajikistan.
J KlieascikovaMSF, Kuala Lumpur, Malaysia.
N SitaliMSF Holland, Amsterdam, The Netherlands.
A RajabzodaNational Tuberculosis Programme, Dushanbe, Tajikistan.
S AvzamovaNational Tuberculosis Programme, Dushanbe, Tajikistan.
B PirmahmadzodaDushanbe City Tuberculosis Programme, Dushanbe City, Tajikistan.
A AungMedecins Sans Frontieres (MSF), Dushanbe, Tajikistan.
M SayfulloevMedecins Sans Frontieres (MSF), Dushanbe, Tajikistan.
R SleitMSF Holland, Amsterdam, The Netherlands.
A SinhaManson Unit, MSF, London, UK.
Médecins Sans Frontières · NLNational Tuberculosis Institute · INMédecins Sans Frontières‎ · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsChildDirectly Observed TherapyHumansAntitubercular Agents

Identifiers

PMID35898123
PMCPMC9341496
OpenAlexW4288074199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.